Variant report
Variant | nsv10214 |
---|---|
Chromosome Location | chr2:205615446-205618100 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:205608885..205610697-chr2:205614525..205616047,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529757537 | chr2:205615459-205615460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534621998 | chr2:205615461-205615462 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs112326522 | chr2:205615467-205615468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs59875139 | chr2:205615472-205615473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs370417560 | chr2:205615488-205615489 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187964453 | chr2:205615495-205615496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562919078 | chr2:205615501-205615502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs556670164 | chr2:205615509-205615510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs575246434 | chr2:205615512-205615513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562096937 | chr2:205615537-205615538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs193227663 | chr2:205615538-205615539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574133109 | chr2:205615556-205615557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs541768366 | chr2:205615557-205615558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560053145 | chr2:205615566-205615567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533400690 | chr2:205615573-205615574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546401849 | chr2:205615584-205615585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545398321 | chr2:205615603-205615604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs563851052 | chr2:205615608-205615609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs140188807 | chr2:205615610-205615611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114718898 | chr2:205615650-205615651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553246453 | chr2:205615707-205615708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567349893 | chr2:205615741-205615742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149907781 | chr2:205615771-205615772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs144984943 | chr2:205615823-205615824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs571190193 | chr2:205615828-205615829 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184368509 | chr2:205615834-205615835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372994162 | chr2:205615864-205615865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559561892 | chr2:205615950-205615951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189299951 | chr2:205615955-205615956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192281456 | chr2:205615978-205615979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs77794078 | chr2:205615993-205615994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548356050 | chr2:205615994-205615995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs35487412 | chr2:205616017-205616018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs554621902 | chr2:205616040-205616041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184152914 | chr2:205616058-205616059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs573208513 | chr2:205616074-205616075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553731850 | chr2:205616088-205616089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578249075 | chr2:205616108-205616109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545458198 | chr2:205616154-205616155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs377513082 | chr2:205616168-205616169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563541624 | chr2:205616171-205616172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530887075 | chr2:205616216-205616217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542773622 | chr2:205616222-205616223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs115091676 | chr2:205616226-205616227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs528303740 | chr2:205616289-205616290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13409132 | chr2:205616346-205616347 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs113981037 | chr2:205616415-205616416 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571250840 | chr2:205616446-205616447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532285973 | chr2:205616451-205616452 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550808660 | chr2:205616476-205616477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Cancer | 20164920 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:205611600-205622800 | Weak transcription | Fetal Heart | heart |
2 | chr2:205615200-205618800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr2:205615200-205618800 | Weak transcription | HSMMtube | muscle |
4 | chr2:205615400-205616400 | Weak transcription | Osteobl | bone |
5 | chr2:205615400-205618400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
6 | chr2:205615400-205628600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr2:205616400-205617200 | Enhancers | Osteobl | bone |